MANA Advisors’s Catheter Precision VTAK Stock Holding History

MANA Advisors’s Portfolio VTAK Stock Details VTAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1	Closed	-$45K	–	23
2021 Q2	$45K	Buy	+1	New	+$41.6K	4.04%	8

Other funds holding VTAK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MANA Advisors's VTAK Position: Q3 2021 in Review

MANA Advisors sold out of Catheter Precision (VTAK) in Q3 2021, closing a stake of 1 share — an estimated $45K sold.

MANA Advisors first reported a position in VTAK in Q2 2021 and held it in 1 quarter. The position peaked at $45K in Q2 2021. 13 funds tracked by Wall St. Rank hold VTAK as of Q3 2021.

MANA Advisors reported no remaining Catheter Precision position as of Q3 2021 after selling out during the quarter.
MANA Advisors sold 1 Catheter Precision share in Q3 2021, an estimated $45K.
MANA Advisors first reported a position in Catheter Precision in Q2 2021 and held it in 1 quarter.
MANA Advisors's Catheter Precision position peaked at $45K in Q2 2021.
13 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2021.

Based on MANA Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.